Pα+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley Says R-MDMA Met Safety Goal in SAD, Details Phase 3 Design for 5-MeO-DMT in TRD; Psilocybin for Smoking Cessation Study Published

Policy Round-Up: State Momentum, Congressional Signals, and Colorado’s Data Build-Out • RAND Survey: Americans Divided on Psilocybin Legalisation • Helus’ Phase 2a Study of Intravenous DMT in MDD Published in Nature Medicine • Transcend’s Phase 2 Study of Methylone in PTSD Publishes in JAMA Psychiatry • Large German Psilocybin Trial Misses Primary Endpoint • Latest Data from Aus Reports 188 Patients Treated • FDA’s ‘One Pivotal Trial’ Default • and more…